• Hexetidine (NSC-17764): Protocols for Biofilm and Oral Infec

  2026-06-17

  Hexetidine (NSC-17764) stands out as a versatile antibacterial agent for oral infections and resilient biofilm models, offering unique advantages over classic antibiotics—especially on medical device surfaces. This guide delivers actionable protocols, data-driven troubleshooting, and strategic comparisons, empowering researchers to maximize antimicrobial efficacy with Hexetidine.

• NF 449: Defining Selectivity for P2X1 Receptors in Purinergi

  2026-06-16

  The reference study establishes NF 449 as the most potent and selective antagonist for P2X1-containing purinergic receptors, enabling precise dissection of ATP-mediated signaling. Its high specificity provides a valuable tool for platelet aggregation and antithrombotic research, setting a new standard for receptor subtype-selective inhibition.

• Ceftazidime in Gram-Negative Infection Research: Protocols &

  2026-06-16

  Ceftazidime, a third-generation cephalosporin, stands apart for its precision in Gram-negative bacterial infection research, particularly against multidrug-resistant Pseudomonas aeruginosa. This article delivers actionable workflows, workflow enhancements, and troubleshooting strategies, translating the latest resistance dynamics into improved experimental designs and outcomes.

• Haloprogin: Applied Workflows for Antifungal and Antimicrobi

  2026-06-15

  Haloprogin’s low MICs and broad-spectrum activity empower robust in vitro and in vivo studies targeting dermatophytes, Candida albicans, and Gram-positive bacteria. This guide translates core research and reference findings into actionable protocols, troubleshooting strategies, and comparative insights for advanced infectious disease experimentation.

• Cefoperazone Sodium Salt: Resistance, Biliary Tract Models &

  2026-06-15

  Explore the advanced scientific properties of Cefoperazone sodium salt, from its resistance to β-lactamase hydrolysis to its unique role in biliary tract infection research. This in-depth article reveals nuanced applications and practical assay considerations beyond standard comparative studies.

• Pharmacogenomics of Chloroquine/Hydroxychloroquine: Systemat

  2026-06-14

  This systematic review by Biswas and Sukasem synthesizes the current evidence on how CYP genetic variants influence the efficacy and safety of chloroquine and hydroxychloroquine. The findings underscore the clinical significance of pharmacogenomic profiling to identify patients at risk for therapeutic failure or toxicity, providing a framework for more individualized therapy.

• Difloxacin HCl: Quinolone Antimicrobial Antibiotic in Advanc

  2026-06-13

  Difloxacin HCl stands out as a dual-action quinolone antimicrobial antibiotic, enabling both high-precision microbial susceptibility assays and breakthrough multidrug resistance research. Its robust solubility and validated workflow integration make it indispensable for labs focused on bacterial DNA replication inhibition and oncology translational models.

• SPP1 Drives ESCC Progression via M2 Macrophage Infiltration

  2026-06-12

  The reference study identifies SPP1 as a critical mediator of tumour-associated macrophage (TAM) infiltration and M2 polarisation in oesophageal squamous cell carcinoma (ESCC), acting through CD44/PI3K/AKT signaling. This mechanistic insight highlights SPP1’s potential as a therapeutic target and underscores the central role of PI3K/AKT pathway modulation in the ESCC tumour microenvironment.

• 3X (DYKDDDDK) Peptide: Precision Tools for Viral Mechanisms

  2026-06-12

  Explore how the 3X (DYKDDDDK) Peptide empowers virology and translational research, with a mechanistic focus on viral-host protein interactions exemplified by ANKLE2 in Zika virus replication. This article integrates structural insight, experimental best practices, and strategic guidance for advancing recombinant workflows, highlighting APExBIO's leadership in epitope tag innovation.

• Applied Workflows with EZ Cap Cy5 Firefly Luciferase mRNA

  2026-06-11

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) uniquely empowers dual-mode quantification of mRNA delivery and translation, streamlining both workflow optimization and mechanistic troubleshooting. Its Cy5 fluorescence and bioluminescence readouts enable real-time monitoring and rigorous translation efficiency assays, setting a new standard for advanced transfection and imaging protocols.

• Technical Protocols for Calpain Inhibitor I, ALLN (A2602)

  2026-06-11

  Calpain Inhibitor I, ALLN is a potent tool for precise inhibition of calpain and cathepsin proteases in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. This reagent is best used in mechanistic studies where protease activity control is critical, but should not be employed for diagnostic or clinical workflows. Its insolubility in water and sensitivity to storage conditions require careful handling to ensure experimental consistency.

• Shufeng Xingbi Therapy Modulates Th1/Th2 Balance and Microbi

  2026-06-10

  The referenced study investigates how Shufeng Xingbi Therapy (SFXBT) corrects immune imbalance and alters intestinal flora in a rat model of allergic rhinitis (AR). The findings demonstrate significant reduction in AR symptoms, immune modulation, and beneficial shifts in gut microbiota, providing mechanistic insights into traditional Chinese medicine approaches for immune-mediated disorders.

• iRhom2 Modulates Olfactory Receptor Adaptation via ADAM17 Pa

  2026-06-10

  Azzopardi et al. reveal that iRhom2, previously understudied in the nervous system, is uniquely expressed in olfactory sensory neurons (OSNs) and regulates odorant receptor repertoire and adaptation via ADAM17-mediated pathways. This work uncovers a feedback loop linking odor exposure, iRhom2 expression, and transcriptional plasticity, providing new insights for sensory GPCR signaling research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-06-09

  This study provides a comprehensive analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The findings highlight the predominance of blaNDM-1 genes on plasmids, frequent multidrug resistance, and efficient horizontal gene transfer—offering critical insights for antimicrobial resistance surveillance and experimental modeling.

• Cinoxacin In Vitro: Antibacterial Spectrum and Resistance Pr

  2026-06-09

  This study systematically characterized cinoxacin’s in vitro efficacy against 419 clinical isolates of gram-negative aerobic bacteria, with a focus on urinary pathogens. Key findings include robust activity against Escherichia coli and related species, well-defined MIC ranges, and rapid selection of resistance under serial drug pressure, offering critical insights for urinary tract infection and antibiotic resistance research.

15069 records 1/1005 page Next 12345 下5页 Last page